NeuroPace
NPCE
Performance
About NeuroPace
NeuroPace is a medical device company that develops the RNS System, a neuromodulation technology for epilepsy. The system provides personalized, responsive treatment by detecting abnormal brain activity and delivering stimulation to reduce seizures, while collecting EEG data to help clinicians optimize care. It targets adults with drug‑resistant focal epilepsy and supports engagement with epilepsy centers, patients, and providers worldwide. Based in the United States, NeuroPace positions itself as a leader in epilepsy treatment through data-driven insights and patient-centered outcomes.
Recent News
NeuroPace AI Suite Leverages 26 Million iEEG Records, Prompting Privacy and Bias Debate
NeuroPace Secures FDA Clearance for ECoG Assistant, First AI‑Driven Epilepsy Tool
Neuropace Inc (NPCE) Q1 2026 Earnings Call Transcript
NeuroPace to Present at the 25th Annual Needham Virtual Healthcare Conference
NeuroPace Announces FDA Approval of ECoG Assistant™, Advancing AI-Driven Epilepsy Care
Recent Deals
No recent deals for this company.